David Bonita Insider Profile

4 Followers
David Bonita, Director at Loxo Oncology, holds 7.93M shares in Ikena Oncology (Ticker: IKNA), holds 20.82K shares in Acutus Medical (Ticker: AFIB), holds 10.65M shares in Prelude Therapeutics (Ticker: PRLD).
tipranks
David Bonita

David Bonita
Loxo Oncology (LOXO)
Director

Ranked #91,242 out of 99,335 Corporate Insiders

Profitable Transactions

40%
8 out of 20 Profitable Transactions

Average Return

-20.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$228M
50.11%
38.18%
6.13%
5.38%
0.20% Others
A breakdown of David Bonita's holdings

Insider Roles

Enliven Therapeutics
(ELVN)
Director, Ten Percent Owner
Third Harmonic Bio, Inc.
(THRD)
Director
Ikena Oncology
(IKNA)
Director
Prelude Therapeutics
(PRLD)
Director, Ten Percent Owner
+3 other positions
Roles that David Bonita holds in companies

Most Profitable Insider Trade

Stock:
Viewray
(VRAYQ)
Rating:Informative Buy
Date:Jan 20, 2017 - Jan 20, 2018
Return:+110.20%
The most profitable trade made by David Bonita

David Bonita's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
LOXO
Loxo Oncology
Dec 12, 2017
Informative Sell
20.63M
$220.82M
Viewray
Apr 25, 2018
Director, Ten Percent Owner
Uninformative Buy
$113.82K
TCDAQ
Tricida
Nov 25, 2022
Informative Sell
2.21M
$0.00
Enliven Therapeutics
Jul 16, 2021
Director, Ten Percent Owner
Informative Buy
10.00M
$114.09M
Repare Therapeutics
Sep 08, 2021
Director
Uninformative Sell
274.79K
$336.18K
Acutus Medical
Jun 15, 2023
Director
Uninformative Buy
$1.15K
Prelude Therapeutics
May 24, 2023
Director, Ten Percent Owner
Informative Buy
5.00M
$12.24M
Ikena Oncology
Sep 14, 2023
Director
Uninformative Buy
$13.95M
Third Harmonic Bio, Inc.
Sep 21, 2022
Director
Uninformative Buy
$86.92M
~AMBI
Ambit
May 24, 2013
Informative Buy
233.37K
List of latest transactions for each holding click on a transaction to see David Bonita's performance on stock

David Bonita insider profile FAQ

What is the percentage of profitable transactions made by David Bonita?
The percentage of profitable transactions made by David Bonita is 40%.
    What is the average return per transaction made by David Bonita?
    The average return per transaction made by David Bonita is -20.50%.
      What stocks does David Bonita hold?
      David Bonita holds: LOXO, VRAYQ, TCDAQ, ELVN, RPTX, AFIB, PRLD, IKNA, THRD, ~AMBI stocks.
        What was David Bonita’s latest transaction?
        David Bonita latest transaction was an Uninformative Buy of ―.
          What was David Bonita's most profitable transaction?
          David Bonita’s most profitable transaction was an Informative Buy of VRAYQ stock on January 20, 2017. The return on the trade was 110.20%.
            What is David Bonita's role in Loxo Oncology?
            David Bonita's role in Loxo Oncology is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.